Concepedia

Michael D. Losiewicz

MD

Statistics

Publications

11

Citations

1K

H-Index

11

Active since

1994

Affiliations

St. Mary's University, Texas(Current)

Zhengzhou University

National Cancer Institute

Central South University

First Affiliated Hospital of Zhengzhou University

Michael D. Losiewicz is an author at St. Mary's University, Texas specializing in cell biology, medicine, and cell death.

Top concepts

MedicineCell BiologyCell DeathCell SignalingApoptosisImmunologyPharmacologyTumor BiologyDrug DiscoveryCancer Research

Publications per year

1994–2024

11

Publications

11

Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275

Michael D. Losiewicz, B. A. Carlson, Gurmeet Kaur et al. · Biochemical and Biophysical Research Communications · 1994 · 345 citations

Molecular Pharmacology, Cdc2 Kinase Activity, Signal Transduction +10

Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy

H.H. Sedlacek, Jörg Czech, Ramachandra Naik et al. · International Journal of Oncology · 1996 · 277 citations

Chemoprevention Strategy, Pharmacotherapy, New Synthetic Flavone +18

Early Induction of Apoptosis in Hematopoietic Cell Lines After Exposure to Flavopiridol

Bernard W. Parker, Gurmeet Kaur, Wilberto Nieves‐Neira et al. · Blood · 1998 · 226 citations · Full text

The activated ATM/p53 pathway promotes autophagy in response to oxidative stress-mediated DNA damage induced by Microcystin-LR in male germ cells

Zhihui Tian, Haohao Liu, Xinghai Chen et al. · Ecotoxicology and Environmental Safety · 2021 · 38 citations · Full text

Mitophagy, Genetics, Apoptosis +18

Long-term exposure to low concentrations of MC-LR induces blood-testis barrier damage through the RhoA/ROCK pathway

Haohao Liu, Xin Zeng, MA Ya et al. · Ecotoxicology and Environmental Safety · 2022 · 32 citations · Full text

1–5 of 11